https://www.onclive.com/onclive-tv/dr-alkali-on-fda-approval-of-inotuzumab-ozagamicin-in-all
Dr. Al-Kali on FDA Approval of Inotuzumab Ozagamicin in ALL

Aref Al-Kali, MD



Aref Al-Kali, MD, hematologist, oncologist, Mayo Clinic, discusses the FDA approval of inotuzumab ozagamicin for the treatment of patients with acute lymphoblastic leukemia (ALL).
Printer Printing...